Antimicrobial resistance is a rapidly growing problem, propagated by inappropriate antimicrobial utilization. Across the United States, health systems have improved use through establishment of antimicrobial stewardship programs as mandated by the 2016 CMS Core Elements. Government mandated antimicrobial stewardship requirements for outpatient facilities mirror those of inpatient facilities, and the high rates of antimicrobial use in these settings urgently calls for enhanced efforts in implementation of antimicrobial stewardship in outpatient settings. The session will focus on appropriate outpatient use of antimicrobial agents [e.g., when to use, dosing, duration] as well as novel methods of improving cost and outcomes. The BCACP Clinical Sessions are part of the professional development program for the recertification of board-certified ambulatory care pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCACP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest. Access to the BCACP Clinical Sessions posttests will be available on December 14, 2022, at www.accp.com/myaccount to anyone who has purchased access to the BCACP posttests. For participants who have not purchased access to the posttest, access can be purchased until 5:30 p.m. on Tuesday, October 18, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 12, 2023.